Why the images matter more than the reports
A prostate cancer review is a records-based clinical assessment. The specialist is trying to answer a specific question: is this cancer confined to the prostate, has it spread, has it responded to treatment, or has it come back? Written radiology reports summarise what one radiologist saw. The original image files let a new team look at the same slices and judge for themselves, which is why most serious reviews ask for the actual DICOM files rather than a PDF summary.
That distinction shapes what you should gather. A report that says 'no suspicious lymph nodes' is useful context, but the reviewing clinician may want to see node size, location and the sequence used. If you only send reports, the review may be limited and you may be asked to obtain the images before a firm opinion is possible. Ask your imaging centre for the full study on disc or through a secure transfer link, and check that the files open before you send them.
The core imaging types a prostate review may involve
Multiparametric MRI of the prostate is the main local staging and diagnostic scan. It combines anatomical sequences with functional ones, and the reporting system used internationally (PI-RADS) grades the likelihood that a lesion is clinically significant. If you have had a prostate MRI, the original study and its report are central to any review.
Bone imaging looks for skeletal spread. A bone scan (scintigraphy) is a long-established option; PSMA PET imaging and other PET tracers are increasingly used and can detect disease that other scans miss. Which one is appropriate depends on your PSA, Gleason grade, prior treatment and the clinical question, and that choice belongs to the treating team.
CT scanning of the abdomen and pelvis is used mainly to look at lymph nodes and organs rather than the prostate itself. Chest imaging may be requested if lung spread is a concern. Ultrasound and biopsy records sit alongside imaging: the biopsy pathology report, including Gleason score and grade group, often matters as much as any scan.
Matching the scan to your actual question
A man recently diagnosed and deciding between surgery and radiotherapy needs different imaging from a man whose PSA is rising years after treatment. In the first case, local staging and nodal assessment dominate. In the second, the question is where the recurrence is, and a PSMA PET scan may be considered where available. A man on active surveillance needs interval MRI and PSA trends rather than a full restaging workup.
This is why a generic 'send me all your scans' request is less useful than a short clinical summary. Write two or three sentences: date of diagnosis, Gleason score and grade group, treatments received, latest PSA and its trend, and the specific decision you face. That summary lets the receiving team tell you which existing studies are relevant and which gaps matter. It does not replace their assessment, and it does not guarantee that a remote review can answer the question.
Practical preparation before you travel
Start with the pathology. Request the original biopsy report and, where relevant, the pathology slides or blocks; a Chinese hospital may wish to review the tissue itself rather than accept an outside diagnosis. Ask whether the slides can be released and how they should be shipped or couriered, since rules differ between laboratories and countries.
Next, assemble the imaging in a usable form. Original DICOM files for MRI, bone scan, CT and any PET study, plus the written reports, are the usual starting point. Include PSA results with dates so the trend is visible, and a list of treatments, operations and medicines with dates. Keep a copy for yourself; do not send your only original discs.
Finally, ask the receiving hospital what it wants before you commit to travel. File formats, disc compatibility, language of reports and whether images can be uploaded in advance are administrative questions for that hospital, and the answers vary. A brief enquiry can clarify the expected records without requiring you to purchase anything first.
What a review in China can and cannot settle
A records-based review can give a specialist's opinion on staging, the reasonableness of prior treatment and possible next options. It cannot examine you, and it cannot confirm fitness for a specific operation or guarantee that a hospital will accept your case. If new imaging is needed, the treating team will say so after seeing your records; some tests may need to be repeated in China because the original images are incomplete or because the clinical question has changed.
Be cautious about any service that promises a definitive answer from a scan alone. Prostate cancer decisions combine imaging, pathology, PSA kinetics and your general health. The clinician who examines you and reviews the full file makes the recommendation. Ask directly what the review will cover, what it will not cover, and what would still need to be confirmed in person.
A sensible next step
If you are considering a prostate cancer review in China, the first useful step is not booking a scan but assembling a file someone can actually read. Start with the pathology report from your biopsy, including the Gleason score and grade group, and ask your laboratory whether the slides or blocks can be released for review. Then collect the original imaging files for every prostate MRI, bone scan, CT or PET study you have had, together with the written reports. Add dated PSA results so the trend is visible, and a short list of treatments, operations and medicines with dates. Keep a copy of everything for yourself before anything leaves your hands.
With that file in order, write a brief summary of the decision you face. Two or three sentences are enough: when you were diagnosed, what treatment you have had, your latest PSA and where it is heading, and the specific question you want answered. A man weighing surgery against radiotherapy and a man with a rising PSA after treatment need different imaging, and a clear question helps the receiving team say which of your existing studies matter and where the gaps are. It also protects you from paying for tests that would not change the decision.
Send that summary through the enquiry form, email or WhatsApp rather than forwarding a complete medical archive at first contact. An initial enquiry is free and does not commit you to a proxy consultation or to any treatment. The team can point out obvious gaps and suggest a relevant next step, while the hospital and its clinicians decide what imaging and assessment your case actually requires. If you want background on the specialty first, you can read more about urology care in China before deciding whether to proceed.
One practical caution about timing. If your symptoms are worsening, or you have new pain, urinary retention or other urgent problems, seek local medical care rather than waiting for an overseas review to be arranged. A records-based opinion is a planning tool, not an emergency route, and it cannot examine you or confirm fitness for a specific operation. Ask the receiving team directly what the review will cover, what it will not cover, and what would still need to be confirmed in person before you book travel.
Sources & scope of this guide
References and official service information relevant to this guide.
- Related treatment reference
- EAU Guidelines on Prostate Cancer
- NICE guideline NG131: Prostate cancer diagnosis and management
- National Cancer Institute: Prostate Cancer Treatment
This is general planning information and has not been individually reviewed by a doctor. Medical decisions and personal treatment advice come from your treating clinicians.
